Document:

Exhibit 10.2

 

SATISFACTION AGREEMENT AND RELEASE 

 

This Satisfaction Agreement and Release (“Agreement”)
is dated as of March ___, 2015 and is made by and between Millennium Healthcare Inc., a Delaware corporation (Millennium Healthcare
Inc. and any subsidiaries of Millennium Healthcare Inc. are collectively referred to herein as the “Company”), and
_________________________ (“Holder”).

 

WHEREAS, Holder is the beneficial owner
of ________________notes in the aggregate principal amount of _____ (the “Notes”);

 

WHEREAS, the Holder and the Company agree
that the Holder shall surrender the Notes in exchange for _________________________ shares of the Company’s Series G Preferred
Stock (the “Satisfaction Shares”);

 

WHEREAS, the exchange of the Notes for
the Satisfaction Shares is being made in reliance upon the exemption from registration provided by Section 3(a)(9) of the Securities
Act of 1933, as amended (the “Act”) and 4(a)2 of the Act;

 

NOW, THEREFORE, in consideration of the
mutual conditions and covenants contained in this Agreement, and for other good and valuable consideration, the sufficiency and
receipt of which is hereby acknowledged, it is hereby stipulated, consented to and agreed by and between the Company and Holder
as follows:

 

1.          On
the date hereof, the Holder shall deliver to the Company the originally executed Notes or an appropriately endorsed affidavit of
loss (the “Affidavit”). And without any action of the Holder as of the execution of this Agreement, the Notes shall
be void and of no further force or effect.

 

    	 

    	 

    

 

2.          The
Holder hereby agrees that in exchange for the issuance of the Satisfaction Shares, Holder shall forego any interest that may be
due on the Notes and as such no interest is due on the Notes.

 

3.          Within
seven business days of the receipt of the original Notes or the Affidavit the Company shall, subject to the satisfaction or waiver
of the conditions set forth in this Agreement and pursuant to Section 3(a)(9) of the Act, exchange the Notes for the Satisfaction
Shares and shall deliver to the Holder the following certificate representing the Satisfaction Shares which certificates shall
be delivered to the Holder as follows:

 

 

 

4.          The
Holder represents that the Holder has the requisite legal capacity, power and authority to enter into, and perform under, this
Agreement and to exchange the Notes and receive the Satisfaction Shares in exchange thereof. The execution, delivery and performance
of this Agreement and performance by such Holder and the consummation by such Holder of the transactions contemplated hereby have
been duly authorized by all requisite corporate, partnership or similar action on the part of such Holder and no further consent
or authorization is required. This Agreement has been duly executed and delivered by the Holder, and constitutes the legal, valid
and binding obligations of the Holder, enforceable against the Holder in accordance with its respective terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally, the enforcement of applicable creditors' rights and remedies and except as rights
to indemnification and to contribution may be limited by federal or state securities laws. Holder understands that by executing
this Agreement, Holder is automatically and irrevocably and contemporaneously exchanging such Holder’s Notes and thereafter
such Notes will be null and void.

 

    	2

    	 

    

 

5.          With
respect to the Notes being exchanged by the Holder (i) the Holder owns, beneficially and of record, good and marketable title to
the Notes free and clear of any taxes or encumbrances; (ii) the Notes being exchanged by the Holder are not subject to any transfer
restriction; (iii) the Holder has not entered into any agreement or understanding with any person or entity to dispose of the Notes;
and (iv) the Holder is conveying to the Company good and marketable title to the Notes, free and clear of any security interests,
liens, adverse claims, encumbrances, taxes or encumbrances.

 

6.          RESERVED.

 

7.          Such
Holder is an accredited investor as defined in Rule 501(a) of Regulation D, as amended, under the Act. Such Holder has accurately
completed the Accredited Investor Questionnaire included with this Agreement. The Holder represents that the Holder has beneficially
owned the Notes ________________.

 

8.          The
Satisfaction Shares to be received by such Holder will be acquired for such Holder’s own account, not as nominee or agent,
and not with a view to the resale or distribution of any part thereof in violation of the Act, and such Holder has no present intention
of selling, granting any participation in, or otherwise distributing the same in violation of the Act without prejudice, however,
to such Holder’s right at all times to sell or otherwise dispose of all or any part of such Satisfaction Shares in compliance
with applicable federal and state securities laws. Nothing contained herein shall be deemed a representation or warranty
by such Holder to hold the Satisfaction Shares for any period of time. Such Holder is not a broker-dealer registered with the Securities
and Exchange Commission under the Securities Exchange Act of 1934 (the “Exchange Act”) or an entity engaged in a business
that would require it to be so registered.

 

    	3

    	 

    

 

9.          Holder
has had the opportunity to review the current business prospects, financial condition and operating history of the Company as set
forth in the filings that the Company has made with the Securities and Exchange Commission, including, but not limited to, the
Company’s annual report on form 10-K (as amended) for the year ended December 31, 2013 which was filed with the Securities
and Exchange Commission on April 18, 2014 and Amendment No. 10 to the Form 10 which was filed with the Securities and Exchange
Commission on January 23, 2015. The Holder has also had the opportunity to ask questions and receive answers from the Company regarding
the terms and conditions pertaining to my execution of this Agreement and the Holder has received all the information Holder consider
necessary or appropriate for deciding whether to exchange such the Notes.

 

10.         No
proceedings are pending or, to the knowledge of the Holder, threatened before any court, arbitrator or administrative or governmental
body that would adversely affect the Holder’s right and ability to surrender and exchange the Notes.

 

11.         The
Holder acknowledges that the exchange of the Notes for the Satisfaction Shares may involve tax consequences to the Holder and that
the contents of this Agreement do not contain tax advice. Holder acknowledges that it has not relied and will not rely upon the
Company with respect to any tax consequences related to the execution of this Agreement, and the consummation of the transactions
contemplated by this Agreement, including the exchange of such Holder’s Notes. The Holder assumes full responsibility for
all such consequences and for the preparation and filing of any tax returns and elections which may or must be filed in connection
with the exchange of the Notes for the Satisfaction Shares.

 

    	4

    	 

    

 

12.         The
Holder understands that the Satisfaction Shares are being offered and exchanged in reliance on specific exemptions from the registration
requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy
of, and the Holder’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of
the Holder set forth herein in order to determine the availability of such exemptions and the eligibility of the Holder to acquire
the Satisfaction Shares. Holder acknowledges that that neither the Securities Exchange Commission nor any state securities commission
has approved or disapproved of the transactions contemplated herein, passed up on the merits or fairness of the transaction; or
passed upon the adequacy or accuracy of the disclosure in this document. If required by applicable securities laws, rules or regulations
the certificates representing the Satisfaction Shares shall bear a restrictive legend substantially in the following form:

 

“NEITHER THE ISSUANCE AND SALE OF
THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE,
SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE
FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING
THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT
SECURED BY THE SECURITIES”

 

13.         
Holder acknowledges that the Satisfaction Shares will be when issued to the Holder “restricted securities” and may
not be sold by the holder absent a registration statement covering the resale of the Satisfaction Shares or an exemption from the
registration requirement.  

 

    	5

    	 

    

 

14.         Neither
the Company, its agents or employees nor the Holder has engaged any broker or finder or incurred any liability for any brokerage
fees, commissions or finders’ fees in connection with the transactions contemplated by this Agreement.

 

14.         Holder
is not now and has not been for at least 90 days prior to the date hereof Holder has not been an Affiliate of the Company. Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 405 under the Act. As used herein “Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

15.         Holder
forever releases and discharges the Company, the Company’s heirs, executors, administrators, subsidiaries, successors, predecessors,
officers (including, without limitation, Dominick Sartorio, Christopher Amandola, Anthony Urbano and David Perry), directors, shareholders,
agents, control persons, past and present employees, insurers, and assigns (collectively, the “Released Parties”) from
all actions, cause of action, suits, debts, dues, sums of money, accounts, reckonings, bonds, bills, specialties, covenants, contracts,
controversies, agreements, promises, variances, trespasses, damages, judgments, extents, executions, claims, and demands whatsoever,
in law, admiralty or equity, against the Released Parties, that Holder or his heirs, executors, administrators and assigns ever
had, now have or hereafter can, shall or may, have for, upon, or by reason of any matter, cause or thing whatsoever, whether or
not known or unknown, from the beginning of the world to the day of the date of this Release, except for the Company’s obligations
contained in this Agreement.

 

    	6

    	 

    

 

16.         The
parties understand and agree that this Agreement, including the facts and circumstances shall forever be deemed confidential between
the parties. Except as required under the statutes, rules or regulations of any federal or state government, government agency,
court of competent jurisdiction, the parties shall not disclose or divulge to others the terms or substance of this Agreement.
Without limiting the generality of the foregoing, any non-disclosure provision in this agreement does not prohibit or restrict
the Company from disclosing the contents and terms of this Agreement in any filing of the Company with the Securities and Exchange
Commission (or any other regulatory filing), or the parties to this Agreement (or their attorneys) from responding to any court
or government action pursuant to applicable law to disclose such information, provided, however, the party whom disclosure is sought
gives the other parties to this Agreement prompt notice thereof so that such party may seek a protective order or other appropriate
remedy.

 

17.         All
parties acknowledge and represent that: (a) they have read this Agreement; (b) they clearly understand this Agreement and each
of its terms; (c) they fully and unconditionally consent to the terms of this Agreement; (d) they have had the benefit and advice
of counsel of their own selection; (e) they have executed this Agreement, freely, with knowledge, and without influence or duress;
(f) they have not relied upon any other representations, either written or oral, express or implied, made to them by any person;
and (g) the consideration received by them has been actual and adequate.

 

18.         This
Agreement contains the entire agreement and understanding concerning the subject matter hereof between the parties and supersedes
and replaces all prior negotiations, proposed agreement and agreements, written or oral. Each of the parties hereto acknowledges
that neither any of the parties hereto, nor agents or counsel of any other party whomsoever, has made any promise, representation
or warranty whatsoever, express or implied, not contained herein concerning the subject hereto, to induce it to execute this Agreement
and acknowledges ands warrants that it is not executing this Agreement in reliance on any promise, representation or warranty not
contained herein.

 

    	7

    	 

    

 

19.         This
Agreement may not be modified or amended in any manner except by an instrument in writing specifically stating that it is a supplement,
modification or amendment to the Agreement and signed by each of the parties hereto.

 

20.         Should
any provision of this Agreement be declared or be determined by any court or tribunal to be illegal or invalid, the validity of
the remaining parts, terms or provisions shall not be affected thereby and said illegal or invalid part, term or provision shall
be severed and deemed not to be part of this Agreement.

 

21.         This
Agreement may be executed in facsimile counterparts, each of which, when all parties have executed at least one such counterpart,
shall be deemed an original, with the same force and effect as if all signatures were appended to one instrument, but all of which
together shall constitute one and the same Agreement.

 

[Signature Page
Follows]

  

    	8

    	 

    

IN WITNESS WHEREOF, the parties
have duly executed this Agreement as of the date first indicated above.

  

	 	 	MILLENNIUM HEALTHCARE INC.
	______________	 	 	 
	(Name)   	 	 	 
	(Title)    	 	 	 
	 	 	 	 
	 	 	By:	 
	 	 	 	(name and title)
	 	 	 	 
	STATE OF __________	)	 	 
	 	) ss.:	 	 
	COUNTY OF ________	)	 	 

 

On March ___, 2015, before the undersigned,
a Notary Public in and for the said County and State, personally appeared _____________ known to me by satisfactory evidence to
be such person, personally appeared and acknowledged he has read and executed the foregoing Satisfaction Agreement and Release
and duly acknowledged to me that he executed the same.

 

	 	Witness my hand and official seal.	 
	 	 	 
	 	 	 
	 	Notary Public in and for said County and State	 

  

	STATE OF __________	)	 	 
	 	) ss.:	 	 
	COUNTY OF ________	)	 	 

 

On March __, 2015, before the undersigned, a
Notary Public in and for the said County and State, personally appeared____________, known to me as an officer of Millennium Health
Care Inc. and to be the person whose name is subscribed on the within instrument, and acknowledged she/he has read and executed
the foregoing Satisfaction Agreement and Release and duly acknowledged to me that she/he has the authority to execute, and has
executed same.

  

	 	Witness my hand and official seal.	 
	 	 	 
	 	 	 
	 	Notary Public in and for said County and State	 

 

    	9Exhibit 10.3

 

NEITHER THIS SECURITY NOR ANY SECURITIES
WHICH MAY BE ISSUED UPON EXERCISE OF THIS SECURITY HAVE BEEN REGISTERED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY U.S. STATE OR OTHER JURISDICTION OR ANY EXCHANGE OR SELF-REGULATORY ORGANIZATION, IN RELIANCE UPON
EXEMPTIONS FROM REGISTRATION UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, AND SUCH OTHER LAWS AND REQUIREMENTS, AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR LISTING OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, SUCH REGISTRATION AND/OR LISTING REQUIREMENTS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH WILL BE REASONABLY ACCEPTABLE TO THE COMPANY.

.

 

MILLENNIUM HEALTHCARE INC.

 

COMMON STOCK PURCHASE WARRANT

 

	Number: _______________	Issue Date: April      , 2015

 

Millennium Healthcare
Inc., a Delaware corporation (the “Company”), having an address at 400 Garden City Plaza, Suite 440 Garden City,
New York 11530, hereby certifies that, for value received, ___________, having an address at ______________, Fax Number: ________,
its permissible transferees, designees, successors and assigns (collectively, the “Holder”), is entitled, subject
to the terms set forth below, to purchase from the Company at any time commencing on the date hereof (the “Effective Date”)
and terminating on the third anniversary of the Issue Date (or such earlier date provided in paragraph 5 hereof), up to 10,000,000
shares (each, a “Share” and collectively the “Shares”) of the Company’s common stock
(the “Common Stock”), at an exercise price per Share equal to $0.025 (the “Exercise Price”).
The number of Shares purchasable hereunder and the Exercise Price are subject to adjustment as provided in Section 4 hereof. The
Company may reduce the Purchase Price for some or all of the Warrants, temporarily or permanently, provided such reduction is made
as to all outstanding Warrants for all Holders of such Warrants. Capitalized terms used and not otherwise defined herein shall
have the meanings set forth in that certain Securities Purchase Agreement (the “Subscription Agreement”), dated
of even date herewith, entered into by the Company, the Holder and the other signatories thereto.

 

As used herein the
following terms, unless the context otherwise requires, have the following respective meanings:

 

(A)           The term “Fair
Market Value” of a share of Common Stock as of a particular date (the “Determination Date”) shall
mean:

 

(a)           If the Company's
Common Stock is traded on an exchange or is quoted on the NASDAQ Global Market, NASDAQ Global Select Market, the NASDAQ Capital
Market, the New York Stock Exchange or the American Stock Exchange, LLC, then the average of the closing sale prices of the Common
Stock for the five (5) Trading Days immediately prior to (but not including) the Determination Date;

 

    	-1-

    	 

    

 

(b)           If the Company's
Common Stock is not traded on an exchange or on the NASDAQ Global Market, NASDAQ Global Select Market, the NASDAQ Capital Market,
the New York Stock Exchange or the American Stock Exchange, Inc., but is quoted on the OTC Bulletin Board or in the over-the-counter
market or Pink Sheets, then the average of the closing bid and ask prices reported for the five (5) Trading Days immediately prior
to (but not including) the Determination Date;

 

(D)           The term “Other
Securities” refers to any stock (other than Common Stock) and other securities of the Company or any other person (corporate
or otherwise) which the holder of the Warrant at any time shall be entitled to receive, or shall have received, on the exercise
of the Warrant, in lieu of or in addition to Common Stock, or which at any time shall be issuable or shall have been issued in
exchange for or in replacement of Common Stock.

 

(E)           The term “Warrant
Shares” shall mean the Common Stock issuable upon exercise of this Warrant.

 

1.           Method of Exercise; Payment.

 

(a)           Cash Exercise.
The purchase rights represented by this Warrant may be exercised by the Holder, in whole or in part, at any time, or from time
to time, by the surrender of this Warrant, together with the notice of exercise form (the "Notice of Exercise")
attached hereto as Exhibit A duly executed, at the principal office of the Company, and by payment to the Company of an
amount equal to the Exercise Price multiplied by the number of the Warrant Shares being purchased, which amount (the “Purchase
Price”) may be paid, at the election of the Holder, by wire transfer or certified check payable to the order of the Company.
The person or persons in whose name(s) any certificate(s) representing Shares shall be issuable upon exercise of this Warrant shall
be deemed to have become the holder(s) of record of, and shall be treated for all purposes as the record holder(s) of, the Shares
represented thereby (and such Shares shall be deemed to have been issued) immediately prior to the close of business on the date
or dates upon which this Warrant is exercised.

 

(b)           Cashless Exercise.

 

(i)           If the Warrant
Shares are not registered pursuant to an effective registration statement at the time of the exercise of this Warrant, then payment
of the Purchase Price may be made at the option of the Holder either in (i) cash, wire transfer or by certified or official bank
check payable to the order of the Company equal to the applicable aggregate Purchase Price, (ii) by delivery of Warrant Shares
in accordance with Section (ii) below or (iii) by a combination of any of the foregoing methods, for the number
of Common Stock specified in such form (as such exercise number shall be adjusted to reflect any adjustment in the total number
of shares of Common Stock issuable to the holder per the terms of this Warrant) and the holder shall thereupon be entitled to receive
the number of duly authorized, validly issued, fully-paid and non-assessable shares of Common Stock (or Other Securities) determined
as provided herein. Notwithstanding the immediately preceding sentence, payment upon exercise may be made in whole or in part in
the manner described in Section (ii) below only with respect to Warrant Shares not included for unrestricted public resale
in an effective Registration Statement on the date notice of exercise is given by the Holder.

 

    	-2-

    	 

    

 

(ii)           Subject to
the provisions herein to the contrary, if the Fair Market Value of one share of Common Stock is greater than the Exercise Price
(at the date of calculation as set forth below), then in lieu of exercising this Warrant for cash, the holder may elect to receive
Warrant Shares equal to the value (as determined below) of this Warrant (or the portion thereof being cancelled) by delivery of
a properly executed Notice of Exercise delivered to the Company by any means described in Section 11, in which event the
Company shall issue to the holder a number of shares of Common Stock computed using the following formula:

 

	 	X=	Y (A-B)
	 		     A
	 	 	 
	Where 	X=	the number of Warrant Shares to be issued to the Holder
	 	 	 
	 	Y=	the number of shares of Warrant Shares purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being exercised (at the date of such calculation)
	 	 	 
	 	A=	Fair Market Value
	 	 	 
	 	B=	Exercise Price (as adjusted to the date of such calculation)

 

For purposes of Rule
144 promulgated under the 1933 Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise
transaction in the manner described above shall be deemed to have been acquired by the Holder, and the holding period for the Warrant
Shares shall be deemed to have commenced, on the date this Warrant was originally issued pursuant to the Subscription Agreement.

 

(c)           Stock Certificates.

 

(i)           Upon the exercise of this Warrant
in compliance with the provisions hereof, the Company shall promptly issue and cause to be delivered to the Holder a certificate
for the Shares purchased by the Holder. Each exercise of this Warrant shall be effective immediately prior to the close of business
on the date (the “Date of Exercise”) that the conditions set forth in Section 1(a) or have been satisfied. On
the first Business Day following the date on which the Company has received each of the Notice of Exercise and the aggregate Exercise
Price (the “Exercise Delivery Documents”), the Company shall transmit an acknowledgment of receipt of the Exercise
Delivery Documents to the Company’s transfer agent (the “Transfer Agent”). On or before the third Business
Day following the date on which the Company has received all of the Exercise Delivery Documents (the “Share Delivery Date”),
the Company shall (X) provided that the Transfer Agent is participating in The Depository Trust Company (“DTC”)
Fast Automated Securities Transfer Program, upon the request of the Holder, credit such aggregate number of shares of Common Stock
to which the Holder is entitled pursuant to such exercise to the Holder’s or its designee’s balance account with DTC
through its Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not participating in the DTC Fast Automated
Securities Transfer Program, issue and dispatch by overnight courier to the address as specified in the Notice of Exercise, a certificate,
registered in the Company’s share register in the name of the Holder or its designee, for the number of shares of Common
Stock to which the Holder is entitled pursuant to such exercise. Upon delivery of the Exercise Delivery Documents, the Holder shall
be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant
has been exercised, irrespective of the date of delivery of the certificates evidencing such Shares.

 

    	-3-

    	 

    

 

(ii)           This Warrant
shall be exercisable, either in its entirety or, from time to time, for part only of the number of Warrant Shares referenced by
this Warrant. If this Warrant is exercised in part, the Company shall issue, at its expense, a new Warrant, in substantially the
form of this Warrant, referencing such reduced number of Shares that remain subject to this Warrant.

 

(d)           Taxes.
The issuance of the Shares upon the exercise of this Warrant, and the delivery of certificates or other instruments representing
such Shares, shall be made without charge to the Holder for any tax or other charge in respect of such issuance.

 

2.           Warrant.

 

(a)           Exchange,
Transfer and Replacement. At any time prior to the exercise hereof, this Warrant may be exchanged upon presentation and surrender
to the Company, alone or with other warrants of like tenor of different denominations registered in the name of the same Holder,
for another warrant or warrants of like tenor in the name of such Holder exercisable for the aggregate number of Shares as the
Warrant or Warrants surrendered.

 

(b)           Replacement
of Warrant. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction, or mutilation
of this Warrant and, in the case of any such loss, theft, or destruction, upon delivery of an indemnity agreement reasonably satisfactory
in form and amount to the Company, or, in the case of any such mutilation, upon surrender and cancellation of this Warrant, the
Company, at its expense, will execute and deliver in lieu thereof, a new Warrant of like tenor.

 

(c) Cancellation;
Payment of Expenses. Upon the surrender of this Warrant in connection with any transfer, exchange or replacement as provided
in this Section 2, this Warrant shall be promptly canceled by the Company. The Holder shall pay all taxes and all other
expenses (including legal expenses, if any, incurred by the Holder or transferees) and charges payable in connection with the preparation,
execution and delivery of Warrants pursuant to this Section 2.

 

(d) Warrant Register.
The Company shall maintain, at its principal executive offices (or at the offices of the transfer agent for the Warrant or such
other office or agency of the Company as it may designate by notice to the holder hereof), a register for this Warrant (the “Warrant
Register”), in which the Company shall record the name and address of the person in whose name this Warrant has been
issued, as well as the name and address of each transferee and each prior owner of this Warrant.

 

3.           Rights and Obligations
of Holders of this Warrant. The Holder of this Warrant shall not, by virtue hereof, be entitled to any rights of a stockholder
in the Company, either at law or in equity; provided, however, that in the event any certificate representing shares
of Common Stock or other securities is issued to the Holder hereof upon exercise of this Warrant, such holder shall, for all purposes,
be deemed to have become the holder of record of such Common Stock on the date on which this Warrant, together with a duly executed
Election to Purchase, was surrendered and payment of the aggregate Exercise Price was made, irrespective of the date of delivery
of such Common Stock certificate.

 

    	-4-

    	 

    

 

4.           Adjustments.

 

(a)           Stock Dividends,
Reclassifications, Recapitalizations, Etc. While this Warrant is outstanding, in the event the Company: (i) pays a dividend
in Common Stock or makes a distribution in Common Stock, (ii) subdivides its outstanding Common Stock into a greater number
of shares, (iii) combines its outstanding Common Stock into a smaller number of shares or (iv) increases or decreases
the number of shares of Common Stock outstanding by reclassification of its Common Stock (including a recapitalization in connection
with a consolidation or merger in which the Company is the continuing corporation), then (1) the Exercise Price on the record
date of such division or distribution or the effective date of such action shall be adjusted by multiplying such Exercise Price
by a fraction, the numerator of which is the number of shares of Common Stock outstanding immediately before such event and the
denominator of which is the number of shares of Common Stock outstanding immediately after such event, and (2) the number
of shares of Common Stock for which this Warrant may be exercised immediately before such event shall be adjusted by multiplying
such number by a fraction, the numerator of which is the Exercise Price immediately before such event and the denominator of which
is the Exercise Price immediately after such event.

 

(b)           Combination:
Liquidation. While this Warrant is outstanding, (i) in the event of a Combination (as defined below), each Holder shall
have the right to receive upon exercise of the Warrant the kind and amount of shares of capital stock or other securities or property
which such Holder would have been entitled to receive upon or as a result of such Combination had such Warrant been exercised immediately
prior to such event (subject to further adjustment in accordance with the terms hereof), and (ii) in the event of (x) a Combination
where consideration to the holders of Common Stock in exchange for their shares is payable solely in cash or (y) the dissolution,
liquidation or winding-up of the Company, the Holders shall be entitled to receive, upon surrender of their Warrant, distributions
on an equal basis with the holders of Common Stock or other securities issuable upon exercise of the Warrant, as if the Warrant
had been exercised immediately prior to such event, less the Exercise Price. Unless paragraph (ii) is applicable to a Combination,
the Company shall provide that the surviving or acquiring Person (the “Successor Company”) in such Combination
will assume by written instrument the obligations under this Section 4 and the obligations to deliver to the Holder
such shares of stock, securities or assets as, in accordance with the foregoing provisions, the Holder may be entitled to acquire.
“Combination” means an event in which the Company consolidates with, merges with or into, or sells all or substantially
all of its assets to another Person, where “Person” means any individual, corporation, partnership, joint venture,
limited liability company, association, joint-stock company, trust, unincorporated organization, government or any agency or political
subdivision thereof or any other entity. In case of any Combination described in this Section 4, the surviving or acquiring
Person and, in the event of any dissolution, liquidation or winding-up of the Company, the Company, shall deposit promptly with
an agent or trustee for the benefit of the Holders such funds, if any, necessary to pay to the Holders the amounts to which they
are entitled as described above. After such funds and the surrendered Warrant are received, the Company shall be required to deliver
a check in such amount as is appropriate (or, in the case or consideration other than cash, such other consideration as is appropriate)
to such Person or Persons as it may be directed in writing by the Holders surrendering such Warrants.

 

    	-5-

    	 

    

 

(c)           Stock
Splits. In the event of a reverse split or a forward split with regard to the Company’s Common Stock (either referred
to as a “Split”), the number of Warrant Shares and the Exercise Price shall adjusted automatically and simultaneously
using the same ratio as used in connection with the Split. For example, in the event of a 1 for 2 reverse split, the Exercise
Price would be doubled and in the event of a 4 for 1 forward split, the Exercise Price would be 1/4th of the pre-Split
Exercise Price.

 

(d)           Notice of
Adjustment. Whenever the Exercise Price or the number of shares of Common Stock and other property, if any, issuable upon exercise
of the Warrant is adjusted, as herein provided, the Company shall deliver to the holders of the Warrant in accordance with Section 10
a certificate of the Company’s Chief Financial Officer setting forth, in reasonable detail, the event requiring the adjustment
and the method by which such adjustment was calculated and specifying the Exercise Price and number of shares of Common Stock issuable
upon exercise of Warrant after giving effect to such adjustment.

 

(e)           Notice of
Certain Transactions. While this Warrant is outstanding, in the event that the Company shall propose (a) to pay any dividend
payable in securities of any class to the holders of its Common Stock or to make any other non-cash dividend or distribution to
the holders of its Common Stock, (b) to offer the holders of its Common Stock rights to subscribe for or to purchase any securities
convertible into shares of Common Stock or shares of stock of any class or any other securities, rights or options, (c) to
effect any capital reorganization, reclassification, consolidation or merger affecting the class of Common Stock, as a whole, or
(d) to effect the voluntary or involuntary dissolution, liquidation or winding-up of the Company, the Company shall, within
the time limits specified below, send to each Holder a notice of such proposed action or offer. Such notice shall be mailed to
the Holders at their addresses as they appear in the Warrant Register (as defined in Section 2(d)), which shall specify
the record date for the purposes of such dividend, distribution or rights, or the date such issuance or event is to take place
and the date of participation therein by the holders of Common Stock, if any such date is to be fixed, and shall briefly indicate
the effect of such action on the Common Stock and on the number and kind of any other shares of stock and on other property, if
any, and the number of shares of Common Stock and other property, if any, issuable upon exercise of each Warrant and the Exercise
Price after giving effect to any adjustment pursuant to Section 4 which will be required as a result of such action.
Such notice shall be given as promptly as possible and (x) in the case of any action covered by clause (a) or (b) above, at least
ten (10) days prior to the record date for determining holders of the Common Stock for purposes of such action or (y) in the case
of any other such action, at least twenty (20) days prior to the date of the taking of such proposed action or the date of participation
therein by the holders of Common Stock, whichever shall be the earlier.

 

5.           Call. If,
after the first anniversary of the Issue Date (x) the Fair Market Value of the Common Stock on such date is 150% greater than the
Fair Market Value of the Common Stock on the Issue Date, (y) the Warrant Shares have been registered under the Securities Act of
1933, as amended (the “1933 Act”) or otherwise upon issuance will be free trading shares without restriction,
and (z) the average ten day trading volume then is at least $250,000, then the Company shall have the right, by delivery to the
Holders of a written notice to such effect (the “Call Notice”) to require the Holders to exercise the Warrants
represented hereby no later than 10 trading days after delivery of the Call Notice, failing which the Warrants will expire and
become forfeited.

 

    	-6-

    	 

    

 

6.           Fractional Shares.
In lieu of issuance of a fractional share upon any exercise hereunder, the Company will issue an additional whole share in lieu
of that fractional share, calculated on the basis of the Exercise Price.

 

7.           Legends.
Unless and until the Warrant Shares are registered under the Securities Act of 1933, or exempt from registration and otherwise
unrestricted as to sale or other transfer, all certificates representing Warrant Shares shall bear a restrictive legend to the
effect that the Shares represented by such certificate have not been registered under the 1933 Act, and that the Shares may not
be sold or transferred in the absence of such registration or an exemption therefrom, such legend to be substantially in the form
of the bold-face language appearing at the top of Page 1 of this Warrant.

 

8.           Disposition
of Warrants or Shares. The Holder of this Warrant, each transferee hereof and any holder and transferee of any Shares, by his
or its acceptance thereof, agrees that no public distribution of Warrants or Shares will be made in violation of the provisions
of the 1933 Act. Furthermore, it shall be a condition to the transfer of this Warrant that any transferee thereof deliver to the
Company his or its written agreement to accept and be bound by all of the terms and conditions contained in this Warrant.

 

9.           Merger or Consolidation.
The Company will not merge or consolidate with or into any other corporation, or sell or otherwise transfer its property, assets
and business substantially as an entirety to another corporation, unless the corporation resulting from such merger or consolidation
(if not the Company), or such transferee corporation, as the case may be, shall expressly assume, by supplemental agreement reasonably
satisfactory in form and substance to the Holder, the due and punctual performance and observance of each and every covenant and
condition of this Warrant to be performed and observed by the Company.

 

10.           Notices.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Subscription Agreement between the Company and the Holder.

 

11.           Reserved.

 

12.           Governing Law.
This Warrant shall be governed by and construed in accordance with the laws of the State of New York applicable to contracts made
and to be performed in the State of New York.

 

13.           Successors
and Assigns. This Warrant shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors
and assigns.

 

14.           Headings.
The headings of various sections of this Warrant have been inserted for reference only and shall not affect the meaning or construction
of any of the provisions hereof.

 

15.           Severability.
If any provision of this Warrant is held to be unenforceable under applicable law, such provision shall be excluded from this Warrant,
and the balance hereof shall be interpreted as if such provision were so excluded.

 

16.           Modification
and Waiver. This Warrant and any provision hereof may be amended, waived, discharged or terminated only by an instrument in
writing signed by the Company and the Holder.

 

    	-7-

    	 

    

 

17.           Specific Enforcement.
The Company and the Holder acknowledge and agree that irreparable damage would occur in the event that any of the provisions of
this Warrant were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that
the parties shall be entitled to an injunction or injunctions to prevent or cure breaches of the provisions of this Warrant and
to enforce specifically the terms and provisions hereof, this being in addition to any other remedy to which either of them may
be entitled by law or equity.

 

18.           Assignment.
This Warrant may be transferred or assigned, in whole or in part, at any time and from time to time by the then Holder by submitting
this Warrant to the Company together with a duly executed Assignment in substantially the form and substance of the Form of Assignment
which accompanies this Warrant, as Exhibit B hereto, and, upon the Company’s receipt hereof, and in any event,
within five (5) business days thereafter, the Company shall issue a warrant to the Holder to evidence that portion of this Warrant,
if any as shall not have been so transferred or assigned.

 

(signature page immediately follows)

 

    	-8-

    	 

    

IN WITNESS WHEREOF, the Company has caused
this Warrant to be duly executed, manually or by facsimile, by one of its officers thereunto duly authorized.

 

	
         

         

         

        Date: April  __, 2015
	
        MILLENNIUM HEALTHCARE INC.

         

         

        By:____________________________________

        Name:    Dominick Sartorio

        Title:      CEO

 

    	-9-

    	 

    
 

EXHIBIT A

TO

WARRANT

 

ELECTION TO PURCHASE

 

To Be Executed by the Holder

in Order to Exercise the Warrant

 

The undersigned Holder hereby elects to
purchase _______ Shares pursuant to the attached Warrant, and requests that certificates for securities be issued in the name of:

 

 

 

(Please type or print name and address)

 

 

 

 

(Social Security or Tax Identification Number)

 

and delivered

to:_________________________________________________________________

___________________________________________________________________.

 

(Please type or print name and address if
different from above)

 

If such number of Shares being purchased
hereby shall not be all the Shares that may be purchased pursuant to the attached Warrant, a new Warrant for the balance of such
Shares shall be registered in the name of, and delivered to, the Holder at the address set forth below.

 

In full payment of the purchase price with
respect to the Shares purchased and transfer taxes, if any, the undersigned hereby tenders payment of $__________ by check, money
order or wire transfer payable in United States currency to the order of [_________]

 

	 	
        HOLDER:

        

        

        

        By:_____________________________________

                   Name:

                   Title:

                   Address:

	
         

         

        Dated:_______________________
	 

 

    	-10-

    	 

    

 

EXHIBIT B

TO

WARRANT

 

FORM OF ASSIGNMENT

(To be signed only on transfer of Warrant)

 

For value received, the undersigned hereby
sells, assigns, and transfers unto _____________ the right represented by the within Warrant to purchase ______ shares of Common
Stock of Millennium Healthcare Inc., a Delaware corporation, to which the within Warrant relates, and appoints ____________________
Attorney to transfer such right on the books of Millennium Healthcare Inc., a Delaware corporation, with full power of substitution
of premises.

 

	Dated:	
 

    By:_______________________________
            Name:
            Title:
            (signature
    must conform to name
            of
    holder as specified on the fact of the Warrant)
	 	
         

         

        Address:

 

 

Signed in the presence of :

 

Dated:

 

    	-11-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00244-of-00352.parquet"}]]